Internet Company, Biotech to Invest Up to $1.5 Billion to Research Age-Related Diseases.
Under the new partnership, Calico and AbbVie will each invest up to $250 million, and potentially another $500 million each, to tackle conditions like cancer and neurodegenerative disorders. The companies said they would share costs and profits from the collaboration equally.
Calico, run by Mr. Levinson and former Genentech colleague Hal Barron, will build a research-and-development center in the San Francisco Bay Area.
Under the new partnership, Calico and AbbVie will each invest up to $250 million, and potentially another $500 million each, to tackle conditions like cancer and neurodegenerative disorders. The companies said they would share costs and profits from the collaboration equally.
Calico, run by Mr. Levinson and former Genentech colleague Hal Barron, will build a research-and-development center in the San Francisco Bay Area.